{"brief_title": "A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.", "brief_summary": "The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.", "condition": "Diabetes Mellitus, Non-Insulin-Dependent", "intervention_type": "Drug", "intervention_name": "glyburide", "criteria": "Children ages 9-16 years with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, with or without oral hypoglycemic therapy, and have an HbA1c greater than 6.4%", "gender": "All", "minimum_age": "9 Years", "maximum_age": "16 Years", "healthy_volunteers": "No", "id": "NCT00035542.xml"}